BioCentury
ARTICLE | Company News

High Througput Genomics, Harvard Medical School deal

December 8, 2008 8:00 AM UTC

The partners will use HTG's quantitative Nuclease Protection Assay (qNPA) technology to develop microRNA biogenesis assays to identify diagnostic markers and therapeutic targets for cancer. qNPA uses ...